1. Assessing the Level of Unmet Need Amongst Ulcerative Colitis Patients in the United States and Europe: 818. (October 2019) Authors: Kershaw, Jim; Lucas, James; Naessens, Dominik Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation. (2nd January 2018) Authors: Stern, Sean; Ward, Alexandra J.; Saint-Laurent Thibault, Catherine; Camacho, Fernando; Rahme, Elham; Naessens, Dominik; Aumais, Guy; Bernard, Edmond-Jean; Bourdages, Raymond; Cohen, Albert; Pare, Pierre; Dyrda, Peter Journal: Journal of medical economics Issue: Volume 21:Number 1(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Different Induction Response Criteria Do Not Influence 1‐Year Response and Remission Rates of Ustekinumab 90 Mg Q8w in Phase III Program: 665. (October 2016) Authors: Naessens, Dominik; Johanns, Jewel; Gasink, Chris Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. (2nd April 2020) Authors: Welty, Margaux; Mesana, Laura; Padhiar, Amie; Naessens, Dominik; Diels, Joris; van Sanden, Suzy; Pacou, Maud Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. (2nd April 2020) Authors: Welty, Margaux; Mesana, Laura; Padhiar, Amie; Naessens, Dominik; Diels, Joris; van Sanden, Suzy; Pacou, Maud Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Indirect Treatment Comparison of the 1‐year Efficacy for Ustekinumab Versus Other Advanced Therapies in Moderate to Severe Ulcerative Colitis: 800. (October 2019) Authors: Welty, Margaux; Mesana, Laura; Padhiar, Amie; Naessens, Dominik; Diels, Joris; Van Sanden, Suzy; Pacou, Maud Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Indirect Treatment Comparison of Ustekinumab Versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Anti‐TNF Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 708. (October 2017) Authors: Mesana, Laura; Pacou, Maud; Naessens, Dominik; Sloan, Sheldon; Gauthier, Aline Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Indirect Treatment Comparison of Ustekinumab versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Conventional Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 709. (October 2017) Authors: Mesana, Laura; Pacou, Maud; Naessens, Dominik; Sloan, Sheldon; Gauthier, Aline Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long‐Term Consequences of Surgery in Patients With Ulcerative Colitis: A Study Using German Claims Data: 850. (October 2019) Authors: Ghiani, Marco; Naessens, Dominik; Takacs, Peter; Myers, David; Maywald, Ulf; Bokemeyer, Bernd; Wilke, Thomas Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S0463 Economic Costs Associated With Reduction in Work Productivity Loss for Ulcerative Colitis Patients Receiving Ustekinumab Using Results From the UNIFI Clinical Trial. (October 2020) Authors: Carlucci, Claudia; Lueza, Béranger; Colonier, Astrid Foix; Kamal, Zahra; Muser, Erik; Naessens, Dominik; Teeple, Amanda Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1 Page Start: S233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗